Viewing nowCombinationAcrab Tablets 30/40 milligrams
Fimasartan Potassium Trihydrate Granules 75mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 202300721 · Approved 2023.02.28 · Insurance code 641908260
Treatment of essential hypertension, improvement of hyperlipidemia, prevention of cardiovascular disease
This medication is used for patients who require concurrent use of two drugs, pimasartan and atorvastatin. First, pimasartan helps control blood pressure in patients with essential hypertension. Atorvastatin is effective in reducing the risk of cardiovascular diseases, particularly important for patients at high risk of myocardial infarction or stroke. Additionally, it contributes to reducing the risk of cardiovascular events in patients with type 2 diabetes and pre-existing heart disease. This drug helps to improve cholesterol and lipid levels in patients with hyperlipidemia, aiding in the prevention of cardiovascular diseases. Thus, this medication is used to improve both hypertension and the risk of cardiovascular diseases.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, fimasartan and atorvastatin. Patients taking fimasartan and atorvastatin as separate medicines may switch to this medicine (a fixed-dose combination with the same amount of each active ingredient) for convenience. ○ Fimasartan 1. Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take it at the same time every day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, the recommended initial dose of this medicine is 30 mg once daily (see Precautions for Use, 9. Administration to elderly patients). 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate ~ severe hepatic impairment (see Precautions for Use, 2. Do not administer to the following patients and 10. Administration to patients with hepatic impairment). 5. Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended (see Precautions for Use, 3. Administer with caution to the following patients). ○ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to reduce LDL cholesterol, it is recommended to use LDL cholesterol levels when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: Efficacy and safety in elderly patients 70 years of age or older are generally similar to those in the general adult patient population.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. This drug should not be administered to patients with severe liver impairment or certain muscular disorders, and should not be taken by children under 10 years of age or by pregnant or breastfeeding women. Patients with a history of alcohol abuse or liver disease, elderly patients, and those with reduced kidney function should take this medication with caution, and it is important to periodically monitor for muscle-related symptoms or blood test results. Since this medication has blood pressure-lowering effects, patients who may experience symptoms of hypotension should be closely monitored while taking it, and caution should be exercised when driving or operating machinery as dizziness or drowsiness may occur. Possible side effects include muscle pain, headache, dizziness, indigestion, fatigue, edema, and rarer occurrences of liver function abnormalities, severe muscle damage, and allergic reactions. Immediate consultation with a doctor is advised if unusual symptoms arise. During the use of this drug, interactions with other medications may occur, particularly when taken with potassium-sparing diuretics, lithium, certain antibiotics, antifungals, and HIV treatments; consultation with healthcare professionals is necessary. Women of childbearing potential should use appropriate contraception while taking this medication, and breastfeeding women should consider stopping breastfeeding or discontinuing the drug. This medication requires special caution when administered to children, the elderly, and patients with liver disorders, especially in the elderly, as their physiological responses may be more sensitive; therefore, dosage adjustments or monitoring may be necessary. In cases of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and appropriate treatment should be provided based on the symptoms. This medication should be kept out of the reach of children, and should be stored tightly sealed in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, preferably at room temperature between 1 degree Celsius and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents degradation.
Light green round film-coated tablet
For domestic use - 30 tablets/box [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 75mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Atorvastatin Calcium Trihydrate 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Atorvastatin Calcium Trihydrate 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Atorvastatin Calcium Trihydrate 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Atorvastatin Calcium Trihydrate 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Fimasartan Potassium Trihydrate Granules 300mg · Atorvastatin Calcium Trihydrate 20.8mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.